|
ZNF383 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.171600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.261680E-02 |
| Normal-vs-Stage2 |
6.372800E-01 |
| Normal-vs-Stage3 |
9.110300E-02 |
| Normal-vs-Stage4 |
8.133500E-02 |
| Stage1-vs-Stage2 |
2.444000E-01 |
| Stage1-vs-Stage3 |
1.11349999998289E-06 |
| Stage1-vs-Stage4 |
1.51626999999044E-05 |
| Stage2-vs-Stage3 |
1.149830E-01 |
| Stage2-vs-Stage4 |
1.056010E-01 |
| Stage3-vs-Stage4 |
8.860000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.337000E-01 |
| Normal-vs-AfricanAmerican |
2.398800E-01 |
| Normal-vs-Asian |
4.813600E-02 |
| Caucasian-vs-AfricanAmerican |
7.646400E-02 |
| Caucasian-vs-Asian |
1.785370E-01 |
| AfricanAmerican-vs-Asian |
4.004000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.185800E-01 |
| Normal-vs-Female |
6.111800E-01 |
| Male-vs-Female |
9.045600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.854800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.935800E-02 |
| Normal-vs-Age(61-80Yrs) |
7.475000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.858800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.975400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.444800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.201200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.462460E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.343560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.194000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.197300E-03 |
| Normal-vs-Grade 2 |
8.996700E-03 |
| Normal-vs-Grade 3 |
7.172400E-01 |
| Normal-vs-Grade 4 |
7.563400E-04 |
| Grade 1-vs-Grade 2 |
2.487600E-01 |
| Grade 1-vs-Grade 3 |
6.117200E-03 |
| Grade 1-vs-Grade 4 |
2.20639999999328E-05 |
| Grade 2-vs-Grade 3 |
3.648700E-04 |
| Grade 2-vs-Grade 4 |
1.11609999020601E-09 |
| Grade 3-vs-Grade 4 |
8.181300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.64349999999658E-05 |
| Normal-vs-ccB subtype |
9.209800E-02 |
| ccA subtype-vs-ccB subtype |
2.82389667205507E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.809800E-01 |
| Normal-vs-N1 |
2.654600E-01 |
| N0-vs-N1 |
2.778000E-01 |
|
|
